journal article Feb 26, 2016

Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis

APMIS Vol. 124 No. 6 pp. 444-452 · Wiley
View at Publisher Save 10.1111/apm.12523
Abstract
Urinary tract infections (UTIs) are among the most common infections in human. Innate immunity recognizes pathogen‐associated molecular patterns (PAMPs) by Toll‐like receptors (TLRs) to activate responses against pathogens. Recently, we demonstrated that MrpH.FimH fusion protein consisting of MrpH from Proteus mirabilis and FimH from Uropathogenic Escherichia coli (UPEC) results in the higher immunogenicity and protection, as compared with FimH and MrpH alone. In this study, we evaluated the innate immunity and adjuvant properties induced by fusion MrpH.FimH through in vitro and in vivo methods. FimH and MrpH.FimH were able to induce significantly higher IL‐8 and IL‐6 responses than untreated or MrpH alone in cell lines tested. The neutrophil count was significantly higher in the fusion group than other groups. After 6 h, IL‐8 and IL‐6 production reached a peak, with a significant decline at 24 h post‐instillation in both bladder and kidney tissues. Mice instilled with the fusion and challenged with UPEC or P. mirabilis showed a significant decrease in the number of bacteria in bladder and kidney compared to control mice. The results of these studies demonstrate that the use of recombinant fusion protein encoding TLR‐4 ligand represents an effective vaccination strategy that does not require the use of a commercial adjuvant. Furthermore, MrpH.FimH was presented as a promising vaccine candidate against UTIs caused by UPEC and P. mirabilis.
Topics

No keywords indexed for this article. Browse by subject →

References
33
[1]
Host–pathogen interactions in urinary tract infection

Greta R. Nielubowicz, Harry L. T. Mobley

Nature Reviews Urology 10.1038/nrurol.2010.101
[4]
Development of an Intranasal Vaccine To Prevent Urinary Tract Infection byProteus mirabilis

Xin Li, C. Virginia Lockatell, David E. Johnson et al.

Infection and Immunity 10.1128/iai.72.1.66-75.2004
[6]
Urinary tract infections: epidemiology, mechanisms of infection and treatment options

Ana L. Flores-Mireles, Jennifer N. Walker, Michael Caparon et al.

Nature Reviews Microbiology 10.1038/nrmicro3432
[8]
Mucosal vaccination of mice with recombinant Proteus mirabilis structural fimbrial proteins

Paola Scavone, Vanessa Sosa, Rafael Pellegrino et al.

Microbes and Infection 10.1016/j.micinf.2004.04.006
[9]
TLR‐ and CXCR1‐dependent innate immunity: insights into the genetics of urinary tract infections

B. Ragnarsdóttir, H. Fischer, G. Godaly et al.

European Journal of Clinical Investigation 10.1111/j.1365-2362.2008.02004.x
[10]
Vandewalle A "Toll‐like receptors and renal bacterial infections" Chang Gung Med J (2008)
[12]
Waging War against UropathogenicEscherichia coli: Winning Back the Urinary Tract

Kelsey E. Sivick, Harry L. T. Mobley

Infection and Immunity 10.1128/iai.01000-09
[14]
FimH Adhesin of Type 1 Fimbriae Is a Potent Inducer of Innate Antimicrobial Responses Which Requires TLR4 and Type 1 Interferon Signalling

Ali A. Ashkar, Karen L. Mossman, Brian K. Coombes et al.

PLOS Pathogens 10.1371/journal.ppat.1000233
[20]
Asadi KM "Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from uropathogenic Escherichia coli (UPEC) isolated in Iran" Iran J Microbiol (2012)
[24]
Current concepts of molecular defence mechanisms operative during urinary tract infection

T. Weichhart, M. Haidinger, W. H. Hörl et al.

European Journal of Clinical Investigation 10.1111/j.1365-2362.2008.02006.x
[29]
Cutting Edge: FimH Adhesin of Type 1 Fimbriae Is a Novel TLR4 Ligand

Karen L. Mossman, M Firoz Mian, Nicole M. Lauzon et al.

The Journal of Immunology 10.4049/jimmunol.181.10.6702
[32]
[33]
Innate immune responses to Proteus mirabilis flagellin in the urinary tract

Ana Umpiérrez, Paola Scavone, David Romanin et al.

Microbes and Infection 10.1016/j.micinf.2013.06.007
Metrics
14
Citations
33
References
Details
Published
Feb 26, 2016
Vol/Issue
124(6)
Pages
444-452
License
View
Funding
Pasteur Institute of Iran
Cite This Article
Mehri Habibi, Mohammad Reza Asadi Karam, Saeid Bouzari (2016). Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis. APMIS, 124(6), 444-452. https://doi.org/10.1111/apm.12523
Related

You May Also Like

Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology

KOK‐FAI KONG, LISA SCHNEPER · 2009

330 citations

The environmental occurrence of Pseudomonas aeruginosa

Stephanie Crone, Martha Vives‐Flórez · 2019

313 citations

Mast cells and angiogenesis

Klas Norrby · 2002

288 citations

Tissue distribution of histo‐blood group antigens.

Vibeke Ravn, Erik Dabelsteen · 2000

256 citations